Sales Reps’ 10 New Year’s Resolutions for the Pharma Industry
With 2017 right around the corner, how did 2016 stack up for the pharmaceutical industry? What does it mean for the future of the industry? What about those who are looking for a career in pharma and are looking for pharmaceutical sales jobs?
#1: Being honest about high salaries for CEO and top executives. To average folks, the numbers are simply astounding. Drug prices are constantly rising, and so are the salaries of top executives. Why is the price of medicine so high? Why does the average CEO need to make nearly $15 million per year (higher than all other major business sectors)? This has led to a high level of distrust and a belief that these top-level execs are downright greedy. There must be a happy medium.
Further Reading:
- “More Top Executives Flee Sinking Crooked Valeant Ship with $ Millions in Bonuses In Tow”; http://sco.lt/6Gm6Ph
- “Oh Snap! Regeneron CEO Says What to Pfizer CEO Ian Read???”; http://sco.lt/8ZED0T
- “Pharma CEO Rips Insurance CEOs a New One! Exposes Salaries, Blames Them for High Drug Prices”; http://sco.lt/6kN065
#2: Fixing the price-fix problem.
Further Reading:
- “More & More Editorials Call for Drug Price Controls”; http://sco.lt/5sPcHp
#3: Meeting growing customer expectations.
#4: Resolving the EpiPen controversy. Outrage continues to grow over the soaring cost of Mylan’s EpiPen.Even Martin Shkreli, who became the poster boy for jacking up drug prices, called Mylan executives “vultures” for the price hike.
Further Reading:
- “Mylan, EpiPen Price Gouger, Ranks No. 2 in U.S. #Pharma Exec Pay!”; http://sco.lt/6lVvf7
- “Yes, Mylan DID Misclassify EpiPen as a Generic, Says Medicaid”; http://sco.lt/5aJWEb
- “Mylan CEO's Mom Used Position with Education Group to Boost EpiPen Sales Nationwide”; http://sco.lt/8tL3kP
Also read: “Pharmaguy's Top Five 2017 New Year's Resolutions for the Pharma Industry”; http://sco.lt/7wwvLd